Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee by Charlie Garnett-Benson, Sarah Warren, Anne Monette, Alexandra Snyder, Janis M Taube, J Carl Barrett, Kurt A Schalper, Brian Topp

Get full text

SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy by Evan J Lipson, Charlie Garnett-Benson, William L Redmond, Robert L Ferris, Marco Ruella, Mark Yarchoan, Kurt A Schalper, Daniela S Thommen, Marleen Kok, Ryan J Sullivan, Harriet M Kluger, Luca Paruzzo, Russell W Jenkins, Anthony R Cillo, Keith Tolley

Get full text

Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy... by James Larkin, Evan J Lipson, Charlie Garnett-Benson, Ignacio Melero, Reinhard Dummer, Paolo A Ascierto, Vanna Chiarion-Sileni, Marta Nyakas, Hao Tang, Inge Marie Svane, Margaret Callahan, Eva Muñoz-Couselo, Jean Jacques Grob, Katriina Peltola, Sonia Dolfi, Carlos Alberto Gomez-Roca, Patrick Djidel, Deepti Warad, Diane Reusser-Wolf

Get full text